Weighted gene co-expression network analysis identified GBP2 connected to PPARα activity and liver cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study investigated how Peroxisome proliferator-activated receptor α (PPARα) activation impacts liver cancer by identifying key genes. Researchers found that higher expression of GBP2 is linked to hepatocellular carcinoma (HCC) progression, suggesting it as a potential biomarker for PPARα activity.
Area Of Science
- Oncology
- Molecular Biology
- Metabolomics
Background
- Liver cancer is a leading cause of cancer death globally, characterized by metabolic and liposomal alterations.
- Peroxisome proliferator-activated receptor α (PPARα) regulates lipid homeostasis and is a potential target in liver cancer treatment.
- Understanding PPARα activation mechanisms and identifying related biomarkers are crucial for advancing liver cancer research.
Purpose Of The Study
- To elucidate the molecular mechanisms of PPARα activation by the agonist WY-14643 in liver cancer.
- To identify candidate biomarkers associated with PPARα activity and assess their impact on liver cancer.
- To evaluate the expression of identified hub genes, particularly GBP2, in relation to clinical outcomes in hepatocellular carcinoma (HCC).
Main Methods
- Differential gene expression analysis (DESeq2) and weighted gene co-expression network analysis (WGCNA) were used to analyze gene expression data.
- Protein-protein interaction networks and KEGG enrichment analysis were performed to identify core hub genes.
- The expression of candidate gene GBP2 was evaluated in relation to clinical outcomes in HCC.
Main Results
- WGCNA identified a brown module negatively correlated with PPARα agonist treatment.
- Core hub genes including CD40, CXCL9, CXCL10, TNFSF14, GBP2, GBP3, APOL3, and CLDN1 were identified.
- Higher expression of GBP2 was significantly associated with HCC progression and negatively correlated with PPARα agonist treatment.
Conclusions
- GBP2 was identified as a key hub gene negatively related to PPARα agonist treatment in liver cancer.
- GBP2 expression correlates with HCC progression, suggesting its potential as a biomarker for PPARα activity.
- Further investigation of GBP2 may offer new insights into PPARα-targeted therapies for liver cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....